Keyphrases
Hematopoietic Stem Cell Transplantation
100%
Mantle Cell Lymphoma
100%
High-dose Therapy
100%
Hematopoietic Stem Cell Transplant
80%
Allogeneic
40%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
40%
Graft-versus-host Disease (GvHD)
20%
Disease Control
20%
Sepsis
20%
Remission
20%
Autologous Transplantation
20%
Allogeneic Transplant
20%
Nineteen
20%
Myeloablative
20%
Long-term Survival
20%
5-year Survival
20%
Progression-free Survival
20%
Transplant-related Mortality
20%
First Remission
20%
Conventional Treatment
20%
Resistant Disease
20%
Second Remission
20%
Extended Disease
20%
Non-ablative
20%
Chemotherapeutic Regimens
20%
Medicine and Dentistry
Drug Megadose
100%
Mantle Cell Lymphoma
100%
Hematopoietic Stem Cell Transplantation
100%
Disease
33%
Transplantation
33%
Sepsis
16%
Overall Survival
16%
Progression Free Survival
16%
Long Term Survival
16%
Graft Versus Host Reaction
16%
Immunology and Microbiology
Drug Megadose
100%
Lymphoma Cell
100%
Hematopoietic Stem Cell Transplantation
100%
Graft-Versus-Host Disease
16%
Overall Survival
16%
Long Term Survival
16%
Progression Free Survival
16%